Your Messages Inbox
Your Article Summary
See Latest ArticlesGen-Probe to Acquire Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases, for $60 Million in Cash Plus Potential Milestone Payments
Gen-Probe, 10/07/09
Gen–Probe Incorporated announced today that it has signed a definitive agreement to acquire Prodesse, Inc., a privately held leader in molecular testing for influenza and other infectious diseases, for approximately $60 million in cash. Gen–Probe's purchase price could increase to up to $85 million if Prodesse achieves certain financial and regulatory milestones in 2010 and 2011.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
A flexible operational unit simplifies the use of disposable equipment and ushers in a new level of biomanufacturing
b3c newswire, 12/02/09
Complete Genomics and GATC Biotech Collaborate on Human Genome Sequencing Projects
b3c newswire, 12/02/09
GSK Update: GSKs Arepanrix? H1N1 pandemic vaccine prequalified by the World Health Organization
GlaxoSmithKline, 12/02/09
Article Search
Sponsor